Free tool
Stocks near their 52-week high
We cover 157 companies trading within 5% of their own 52-week high. The median market value in the group is $4.92B. Across the group, the median move over the past trading day is 0.00%. 99% of the 152 with a 200-day average trade above it. Price change over the past year runs from +18.7% to +222.0% across the middle 80 percent of the group, with a median of +56.2%. Across the group, 2 companies currently carry a tier A volume signal.
Other lists in this group
Table
157 of 3,992 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | $270.00 | +1.23% | +31.66% | +55.40% |
| JNJB34.SA | Johnson & Johnson | 92.80 BRL | +2.16% | +24.99% | +47.82% |
| ABBV | AbbVie Inc. | $262.90 | −0.11% | +16.53% | +29.36% |
| ABBV34.SA | AbbVie Inc. | 84.88 BRL | −0.29% | +9.50% | +21.88% |
| MRCK34.SA | Merck & Co., Inc. | 101.37 BRL | +20.05% | +39.73% | +81.07% |
| MRK | Merck & Co., Inc. | $153.10 | +16.14% | +44.89% | +86.85% |
| AMGN34.SA | Amgen Inc. | 81.32 BRL | +13.94% | +69.69% | +47.79% |
| AMGN | Amgen Inc. | $440.34 | +12.02% | +36.35% | +56.24% |
| TMO | Thermo Fisher Scientific Inc. | $633.71 | +9.94% | +7.06% | +30.17% |
| PFIZ34.SA | Pfizer Inc. | 36.48 BRL | +12.73% | +10.34% | +11.58% |
| PFE | Pfizer Inc. | $28.30 | +12.08% | +16.16% | +18.72% |
| BMYB34.SA | Bristol-Myers Squibb Company | 349.41 BRL | +12.49% | +17.24% | +40.74% |
| VRTX | Vertex Pharmaceuticals Incorporated | $547.29 | +11.60% | +21.05% | +40.66% |
| BMY | Bristol-Myers Squibb Company | $67.57 | +6.24% | +27.70% | +47.01% |
| REGN34.SA | Regeneron Pharmaceuticals, Inc. | 70.98 BRL | +20.22% | +2.34% | +33.80% |
| REGN | Regeneron Pharmaceuticals, Inc. | $814.79 | +17.21% | +5.24% | +39.36% |
| ARGX | argenx SE | $1,047.10 | +20.05% | +24.66% | +47.90% |
| A1RG34.SA | argenx SE | 209.16 BRL | +14.71% | +11.37% | +36.97% |
| TAK | Takeda Pharmaceutical Company Limited | $18.23 | +4.05% | +16.71% | +22.68% |
| TAKP34.SA | Takeda Pharmaceutical Company Limited | 92.25 BRL | +2.81% | +12.61% | +18.03% |
| C1AH34.SA | Cardinal Health, Inc. | 1,234.64 BRL | +2.68% | +6.79% | +52.41% |
| BDX | Becton, Dickinson and Company | $190.21 | +14.35% | +24.91% | +25.97% |
| NTRA | Natera, Inc. | $338.45 | +34.19% | +47.90% | +107.59% |
| RVMD | Revolution Medicines, Inc. | $215.44 | +17.18% | +172.64% | +466.35% |
| T1EV34.SA | Teva Pharmaceutical Industries Limited | 97.74 BRL | +24.04% | +17.29% | +94.70% |
| TEVA | Teva Pharmaceutical Industries Limited | $37.92 | +19.73% | +22.52% | +110.08% |
| A | Agilent Technologies, Inc. | $155.08 | +10.35% | +12.88% | +31.46% |
| IQV | IQVIA Holdings Inc. | $261.51 | +7.64% | +16.04% | +38.51% |
| ONC | BeOne Medicines AG | $375.80 | +13.72% | +20.83% | +25.21% |
| WAT | Waters Corporation | $414.17 | +7.88% | +8.43% | +40.57% |
| RPRX | Royalty Pharma plc | $61.80 | +3.05% | +60.57% | +74.00% |
| I1LM34.SA | Illumina, Inc. | 232.57 BRL | +19.43% | +55.21% | +113.13% |
| ILMN | Illumina, Inc. | $224.84 | +16.51% | +67.35% | +125.88% |
| D1EX34.SA | DexCom, Inc. | 9.21 BRL | +28.45% | +22.96% | +9.64% |
| DXCM | DexCom, Inc. | $88.96 | +18.85% | +33.69% | +16.47% |
| BIIB | Biogen Inc. | $221.07 | +7.52% | +24.32% | +62.12% |
| C1NC34.SA | Centene Corporation | 340.30 BRL | −2.49% | +53.30% | +116.61% |
| BIIB34.SA | Biogen Inc. | 188.29 BRL | +9.47% | +16.95% | +47.86% |
| LH | Labcorp Holdings Inc. | $335.72 | +6.84% | +33.74% | +21.14% |
| DGX | Quest Diagnostics Incorporated | $245.00 | +3.84% | +42.24% | +38.12% |
| ROIV | Roivant Sciences Ltd. | $36.75 | +8.60% | +67.58% | +206.51% |
| INCY | Incyte Corporation | $128.12 | −1.39% | +26.33% | +51.01% |
| I1NC34.SA | Incyte Corporation | 328.02 BRL | +11.19% | +18.38% | +41.91% |
| GH | Guardant Health, Inc. | $170.92 | +19.01% | +68.00% | +169.17% |
| THC | Tenet Healthcare Corporation | $274.19 | +4.40% | +37.47% | +50.70% |
| GMAB | Genmab A/S | $33.75 | +16.38% | +6.07% | +36.20% |
| SOLV | Solventum Corporation | $91.53 | +6.22% | +15.83% | +25.57% |
| CRL | Charles River Laboratories International, Inc. | $295.10 | +22.74% | +45.79% | +81.27% |
| EXEL | Exelixis, Inc. | $56.10 | −0.73% | +28.73% | +45.68% |
| RVTY | Revvity, Inc. | $126.35 | +13.31% | +28.91% | +42.93% |
| B1MR34.SA | BioMarin Pharmaceutical Inc. | 166.77 BRL | +12.08% | −0.14% | +4.97% |
| HALO | Halozyme Therapeutics, Inc. | $107.06 | +28.29% | +52.27% | +46.30% |
| T1CH34.SA | Bio-Techne Corporation | 12.60 BRL | +4.13% | +17.24% | +23.42% |
| TECH | Bio-Techne Corporation | $72.38 | +0.43% | +21.73% | +29.33% |
| PRAX | Praxis Precision Medicines, Inc. | $377.37 | +27.57% | +31.76% | +704.28% |
| KYMR | Kymera Therapeutics, Inc. | $125.55 | +18.26% | +72.55% | +197.09% |
| BIO | Bio-Rad Laboratories, Inc. | $388.64 | +17.41% | +27.31% | +32.71% |
| HSIC | Henry Schein, Inc. | $90.38 | +5.45% | +17.65% | +31.02% |
| RGEN | Repligen Corporation | $180.30 | +24.05% | +9.70% | +51.67% |
| APGE | Apogee Therapeutics, Inc. | $134.95 | +0.58% | +78.08% | +257.11% |
| NUVL | Nuvalent Inc | $123.96 | 0.00% | +22.93% | +62.83% |
| BIO-B | Bio-Rad Laboratories, Inc. | $365.08 | +18.01% | +17.50% | +47.78% |
| TWST | Twist Bioscience Corporation | $150.06 | +69.46% | +363.29% | +451.89% |
| IMVT | Immunovant, Inc. | $43.89 | +12.83% | +69.39% | +189.13% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $84.84 | +1.17% | +81.55% | +179.08% |
| HQY | HealthEquity, Inc. | $104.42 | +3.14% | +14.66% | +18.69% |
| TXG | 10x Genomics, Inc. | $64.26 | +36.58% | +286.64% | +358.35% |
| SRRK | Scholar Rock Holding Corporation | $60.04 | +21.61% | +40.28% | +74.18% |
| HNGE | Hinge Health, Inc. | $90.50 | +20.27% | +98.64% | +56.66% |
| CHE | Chemed Corporation | $548.56 | +5.98% | +29.61% | +20.79% |
| CGON | CG Oncology, Inc. | $78.42 | +7.99% | +87.65% | +196.15% |
| E2XE34.SA | Exelixis, Inc. | 137.40 BRL | −2.25% | +23.92% | +23.92% |
| CNTA | Centessa Pharmaceuticals plc | $40.50 | 0.00% | +70.96% | +143.24% |
| TVTX | Travere Therapeutics, Inc. | $67.12 | +20.05% | +69.84% | +284.86% |
| TFX | Teleflex Incorporated | $138.74 | +3.38% | +13.97% | +8.06% |
| SHC | Sotera Health Company | $19.54 | +10.02% | +10.46% | +18.42% |
| MMSI | Merit Medical Systems, Inc. | $90.54 | +15.65% | +4.73% | −0.28% |
| ACAD | ACADIA Pharmaceuticals Inc. | $29.58 | +13.73% | +12.51% | +11.33% |
| DYN | Dyne Therapeutics, Inc. | $26.36 | +1.78% | +42.49% | +93.26% |
| HAE | Haemonetics Corporation | $106.60 | +29.15% | +33.28% | +93.71% |
| ELVN | Enliven Therapeutics, Inc. | $60.87 | +13.22% | +291.67% | +194.32% |
| CON | Concentra Group Holdings Parent, Inc. | $34.95 | +6.91% | +81.01% | +50.93% |
| HTFL | Heartflow, Inc. | $48.94 | +91.25% | +68.93% | +40.79% |
| ITGR | Integer Holdings Corporation | $125.19 | +24.72% | +63.05% | +15.84% |
| ADPT | Adaptive Biotechnologies Corporation | $26.16 | +16.16% | +64.42% | +101.70% |
| IDYA | IDEAYA Biosciences, Inc. | $41.58 | +14.99% | +22.84% | +66.32% |
| ABCL | AbCellera Biologics Inc. | $12.24 | +131.38% | +256.85% | +181.38% |
| RCUS | Arcus Biosciences, Inc. | $30.76 | +13.72% | +32.07% | +191.29% |
| CPRX | Catalyst Pharmaceuticals Inc | $31.49 | 0.00% | +36.03% | +55.97% |
| OGN | Organon & Co. | $13.77 | +1.85% | +90.95% | +50.67% |
| IMNM | Immunome, Inc. | $28.75 | +23.82% | +38.09% | +188.94% |
| AVAH | Aveanna Healthcare Holdings Inc. | $13.62 | +37.71% | +68.56% | +73.50% |
| ATAI | AtaiBeckley Inc. | $7.39 | +2.92% | +90.96% | +61.71% |
| AXGN | AxoGen, Inc. Common Stock | $51.58 | +25.35% | +66.39% | +219.58% |
| PGEN | Precigen, Inc. | $7.42 | +34.18% | +73.36% | +61.66% |
| CDNA | CareDx, Inc. | $50.96 | +42.55% | +166.25% | +283.45% |
| PHVS | Pharvaris N.V. | $37.00 | +9.97% | +39.73% | +55.59% |
| RAPP | Rapport Therapeutics, Inc. | $52.50 | +25.12% | +86.77% | +250.70% |
| ATRC | AtriCure, Inc. | $48.17 | +21.18% | +22.66% | +29.14% |
| HRMY | Harmony Biosciences Holdings, Inc. | $39.66 | +10.88% | +6.10% | +4.23% |
| NEO | NeoGenomics, Inc. | $17.37 | +29.63% | +47.70% | +145.34% |
| ADUS | Addus HomeCare Corporation | $120.71 | +1.25% | +13.26% | +4.50% |
| PVLA | Palvella Therapeutics, Inc. | $154.33 | +8.04% | +53.90% | +173.39% |
| MD | Pediatrix Medical Group, Inc. | $26.95 | +0.34% | +26.59% | +56.87% |
| ZYME | Zymeworks Inc. | $29.31 | +29.61% | +10.09% | +96.28% |
| SEM | Select Medical Holdings Corp | $16.51 | −0.12% | +12.30% | +28.14% |
| VIR | Vir Biotechnology, Inc. | $11.08 | +25.20% | +86.53% | +111.85% |
| BLFS | BioLife Solutions, Inc. | $37.00 | +15.70% | +54.88% | +45.50% |
| FBRX | Forte Biosciences, Inc. | $76.99 | +0.44% | +226.09% | +589.87% |
| A2RR34.SA | Arrowhead Pharmaceuticals, Inc. | 57.60 BRL | +8.15% | +25.08% | +298.89% |
| LBRX | LB Pharmaceuticals Inc | $48.17 | +37.85% | +135.64% | +178.41% |
| REPL | Replimune Group, Inc. | $15.88 | +196.82% | +78.43% | +187.16% |
| SPTX | Seaport Therapeutics, Inc. | $27.84 | +39.90% | +40.32% | +40.32% |
| CGEM | Cullinan Therapeutics, Inc. | $22.85 | +30.80% | +125.79% | +188.15% |
| KALV | KalVista Pharmaceuticals Inc | $27.00 | 0.00% | +74.64% | +98.68% |
| ANRO | Alto Neuroscience, Inc. | $36.53 | +33.22% | +120.19% | +786.65% |
| MGTX | MeiraGTx Holdings plc | $14.92 | +26.23% | +91.04% | +100.54% |
| DRTS | Alpha Tau Medical Ltd. | $14.96 | +29.52% | +209.73% | +343.92% |
| NUTX | Nutex Health Inc. | $195.92 | +31.46% | +32.21% | +118.22% |
| CRON.TO | Cronos Group Inc. | 4.95 CAD | +23.75% | +34.15% | +39.83% |
| CRON | Cronos Group Inc. | $3.55 | +24.56% | +31.48% | +38.67% |
| AVNS | Avanos Medical Inc | $24.99 | +0.04% | +123.52% | +110.53% |
| J2AZ34.SA | Jazz Pharmaceuticals plc | 88.80 BRL | −0.54% | +35.66% | +35.66% |
| ABUS | Arbutus Biopharma Corporation | $5.19 | +17.69% | +8.81% | +42.19% |
| CADL | Candel Therapeutics, Inc. | $13.28 | +37.19% | +144.12% | +124.70% |
| B2RK34.SA | Bruker Corporation | 30.63 BRL | −0.49% | +63.27% | +63.27% |
| TALK | Talkspace, Inc. | $5.25 | +0.77% | +49.57% | +93.73% |
| ACHV | Achieve Life Sciences, Inc. | $8.27 | +33.82% | +66.40% | +177.52% |
| VREX | Varex Imaging Corporation | $18.48 | +66.04% | +58.63% | +61.40% |
| SOPH | SOPHiA GENETICS SA | $8.53 | +53.14% | +82.66% | +156.16% |
| OABI | OmniAb, Inc. | $4.81 | +144.16% | +155.85% | +198.76% |
| GUD.TO | Knight Therapeutics Inc. | 9.76 CAD | −0.81% | +65.14% | +50.39% |
| SGMT | Sagimet Biosciences Inc. | $10.86 | +49.38% | +81.30% | +39.59% |
| ANGO | AngioDynamics, Inc. | $15.69 | +9.41% | +23.74% | +56.74% |
| CTNM | Contineum Therapeutics, Inc. | $17.02 | +20.20% | +49.43% | +70.03% |
| EOLS | Evolus, Inc. | $8.78 | +41.16% | +30.65% | +15.83% |
| PRLD | Prelude Therapeutics Incorporated | $6.56 | +41.38% | +140.29% | +412.50% |
| PBYI | Puma Biotechnology, Inc. | $9.16 | +14.93% | +58.75% | +79.61% |
| KSI.TO | kneat.com, inc. | 6.50 CAD | +0.46% | +30.52% | +19.93% |
| FRX.TO | Fennec Pharmaceuticals Inc. | 17.00 CAD | +21.86% | +63.30% | +36.00% |
| TBRG | TruBridge Inc | $26.24 | 0.00% | +25.55% | +30.42% |
| IKT | Inhibikase Therapeutics, Inc. | $2.49 | +7.79% | +27.69% | +39.11% |
| RCEL | AVITA Medical, Inc. | $10.59 | +129.72% | +205.19% | +133.77% |
| SMTI | Sanara MedTech Inc. | $34.65 | +30.07% | +50.00% | +2.09% |
| BDSX | Biodesix, Inc. | $30.60 | +45.51% | +373.68% | +225.53% |
| ORMP | Oramed Pharmaceuticals Inc. | $5.34 | +28.06% | +96.84% | +159.19% |
| ASRT | Assertio Holdings Inc | $23.50 | 0.00% | +157.11% | +103.46% |
| EMPG | Empro Group Inc | $17.36 | 0.00% | 0.00% | +76.60% |
| LOVE.TO | Cannara Biotech Inc. | 1.99 CAD | +5.29% | +11.80% | +11.80% |
| CPIX | Cumberland Pharmaceuticals Inc. | $8.97 | +69.86% | +125.38% | +163.82% |
| A2ZT34.SA | Azenta, Inc. | 14.16 BRL | +16.64% | +50.80% | +50.80% |
| RLYB | Rallybio Corporation | $16.88 | +4.49% | +198.44% | +257.63% |
| INCR | InterCure Ltd. | $5.95 | +546.74% | +477.67% | +265.03% |
| INMB | INmune Bio Inc. | $2.45 | +42.98% | +58.77% | +19.56% |
| RNXT | RenovoRx, Inc. | $1.49 | +64.28% | +78.44% | +61.08% |
| BFRI | Biofrontera Inc. | $1.53 | +37.84% | +111.03% | +77.91% |
| APS.TO | Aptose Biosciences Inc | 2.40 CAD | 0.00% | +18.81% | +50.00% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.